Related Experiment Video
Updated: Aug 13, 2026
09:27
DNA Microarrays: Sample Quality Control, Array Hybridization and Scanning
Published on: March 15, 2011
Molecular profiling of high-risk neuroblastoma by cDNA array
Iacopo Sardi1, Veronica Tintori, Cinzia Marchi
1Unita di Oncoematologia, Ospedale Pediatrico A. Meyer, via L. Giordano 13, 50132 Florence, Italy. iacoposardi@hotmail.com
International Journal of Molecular Medicine
|April 17, 2002
Summary
This study used cDNA arrays to identify gene expression changes in neuroblastoma, finding specific up-regulated genes like TMSB10 and TNFRSF10A. This offers new insights into pediatric tumors and potential adjuvant therapy strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Neuroblastoma is a common pediatric cancer.
- Understanding gene expression is crucial for diagnosis and treatment.
Purpose of the Study:
- To investigate gene expression alterations in disseminated neuroblastoma using cDNA array technology.
- To identify specific genes involved in neuroblastoma development and progression.
Main Methods:
- Analysis of three stage IV neuroblastoma tumors and one cell line (SK-N-FI).
- Utilized cDNA array technique for expression profiling.
- Confirmed findings with semiquantitative RT-PCR and Northern blotting.
Main Results:
- Identified highly expressed and down-regulated genes in tumor samples compared to the cell line.
- Observed up-regulation of basic transcription factors, growth factors, and receptors including NSEP, MM1, thymosin beta10 (TMSB10), and TNF-R superfamily member 10A (TNFRSF10A).
- Neuroblastoma samples lacked N-myc overexpression.
Conclusions:
- cDNA array technology is effective for identifying genes in neuroblastoma genesis and progression.
- Findings provide new insights into pediatric tumors.
- Potential role in guiding adjuvant therapy for neuroblastoma patients.
